Exam 1 - Oncology (neoplasia, pathology, chemotherapy) Flashcards

1
Q

neoplasm

A

new growth, malignant or benign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

tumor

A

nonspecific term meaning lump or swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cancer

A

any malignant neoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name the 4 “plasias”

A

hyperplasia
metaplasia
dysplasia
anaplasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hyperplasia

A

increase in # of cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

metaplasia

A

substitution of one type of tissue for another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

dysplasia

A

loss of normal cell architecture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

anaplasia

A

loss of structural differentiation, cell dedifferentiate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name the 7 “omas”

A

carcinoma
adenocarcinoma
sarcoma
lymphoma (and leukemia)
melanoma
blastoma
teratoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

type of cancer normally most prevalent in younger pts

A

blastomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

v-Src is a _____ (oncogene or tumor suppressor)

A

oncogene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

RB1 is a _____ (oncogene or tumor suppressor)

A

tumor suppressor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

biggest causes of preventable cancer (and ones that decrease time to cancer start)

A

smoking
UV exposure
obesity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EGFR mutation involves ____ (is it an activating mutation or suppressing one?)

A

activating: cells begin to grow unchecked because EGFR is a tyrosine kinase - these act as oncogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

BRCA1 and BRCA2 are _____ (oncogene or tumor suppressor)

A

tumor suppressors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Olaparib class

A

PARP inhibitor
-primarily used for cancers with BRCA1/2 mutations

17
Q

Olaparib use

A

Not an enzyme, therefore does not bind active site. These drugs bind PARP to DNA so it is permanently stuck there and PARP is unable to go to strand breaks elsewhere like it normally would. Now it accumulates more and more DNA damage until eventually cells cannot survive

18
Q

G0/G1 phase of cell cycle

A

cell is inactive or accumulating building blocks required for division

19
Q

S phase of cell cycle

A

cell replicating DNA

20
Q

G2 phase of cell cycle

A

cell assembling machinery for chromosomal segregation and cytokenesis (“double check” step)

21
Q

M phase of cell cycle

A

Mitosis - cell replicates its chromosomes and then segregates them, producing two identical nuclei in preparation for cell division

22
Q

common chemotherapies for S phase

A

DNA replication phase so:
-antimetabolites
-antifolates
-topo isomerase inhibitors

23
Q

common chemotherapies for G2 phase

A

sister chromatid separation so:
-Topo2 inhibitors

24
Q

common chemotherapies for M phase

A

chromosome segregation so:
-microtubule inhibitors

25
Q

common chemotherapies for G0 phase

A

resting phase so:
none

26
Q

common chemotherapies for G1 phase

A

mitogenic signaling so:
-kinase inhibitors
-hormone inhibitors

27
Q

non-specific common chemotherapies

A

DNA damaging agents so:
-alkylators
-intercalaters

28
Q

proteins driving cell cycle (oncogenes)

A

KRas

29
Q

proteins halting cell cycle (tumor suppressors)

A

RB1
p53
p16 (associated with melanoma)

30
Q

“master regulators” of cell cycle initiation

A

cyclin D
CDK4/6

31
Q

palbociclib

A

CDK4/6 kinase inhibitor
not cell cycle specific

32
Q

palbociclib AE

A

neutropenia
nausea
fatigue
diarrhea
vomiting

33
Q

palbociclib used for what cancers

A

cancers that arise due to BRCA1/2 mutations

34
Q

palbociclib is technically non-specific but targets mostly what phase of the cell cycle

A

G1

35
Q

Chemotherapy kills a constant _____ of cells not a constant ______ of tumor cells. Like antibiotics, it targets cells ______ to drug.

A

fraction, number, resistant

36
Q

CHOP

A

cyclophosphamide (alkylating agent)
doxorubicin (anthracycline)
vincristine (microtubule inhibitor)
prednisone (steroid)

37
Q

combo chemo tends to result in ____&____

A

-no additive toxicity with non-overlapping drug toxicities (same class for example)
-increased cell killing

38
Q

explain drug resistance to chemotherapy

A

-altered drug metabolism
-changes in drug target or fxn
-physiological changes that promote resistance
-cell survival mechanisms